How JustAnswer Works:
  • Ask an Expert
    Experts are full of valuable knowledge and are ready to help with any question. Credentials confirmed by a Fortune 500 verification firm.
  • Get a Professional Answer
    Via email, text message, or notification as you wait on our site.
    Ask follow up questions if you need to.
  • 100% Satisfaction Guarantee
    Rate the answer you receive.
Ask Tina Your Own Question
Tina, Lawyer
Category: Legal
Satisfied Customers: 8775
Experience:  JD, BBA Over 25 years legal and business experience.
Type Your Legal Question Here...
Tina is online now
A new question is answered every 9 seconds

It is my understanding that the Companies that have the

Customer Question

It is my understanding that the Companies that have the patents on Yondelis or ET-743 is Zeltia and Johnson and Johnson. Is this correct?
Submitted: 1 year ago.
Category: Legal
Expert:  alex reese replied 1 year ago.


Expert:  alex reese replied 1 year ago.

Yondelis is a drug marketed by Janssen Prods and is included in one NDA. There is one patent protecting this drug. This drug has thirty-eight patent family members in thirty-five countries.
The generic ingredient in YONDELIS is trabectedin. There are four drug master file entries for this compound. Additional details are available on the trabectedin profile page.

Yondelis is purportedly protected under patent No. 8,895,557....and the patent is assigned to Pharma Mar, S.A., Sociedad Unipersonal (Madrid, ES)